These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 8407550
21. Prevention by antioxidants of heterocyclic amine-induced carcinogenesis in a rat medium-term liver bioassay: results of extended and combination treatment experiments. Hirose M, Futakuchi M, Tanaka H, Orita SI, Ito T, Miki T, Shirai T. Eur J Cancer Prev; 1998 Feb; 7(1):61-7. PubMed ID: 9511852 [Abstract] [Full Text] [Related]
22. Effects of cigarette smoke and a heterocyclic amine, MeIQx on cytochrome P-450, mutagenic activation of various carcinogens and glucuronidation in rat liver. Mori Y, Koide A, Kobayashi Y, Furukawa F, Hirose M, Nishikawa A. Mutagenesis; 2003 Jan; 18(1):87-93. PubMed ID: 12473741 [Abstract] [Full Text] [Related]
23. Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats. Wei M, Hori TA, Ichihara T, Wanibuchi H, Morimura K, Kang JS, Puatanachokchai R, Fukushima S. Cancer Lett; 2006 Jan 18; 231(2):304-8. PubMed ID: 16399231 [Abstract] [Full Text] [Related]
24. Induction of liver preneoplastic lesions by aminophenylnorharman, formed from norharman and aniline, in male F344 rats. Kawamori T, Totsuka Y, Ishihara J, Uchiya N, Sugimura T, Wakabayashi K. Cancer Lett; 2001 Feb 26; 163(2):157-61. PubMed ID: 11165749 [Abstract] [Full Text] [Related]
28. Carcinogenic risk of heterocyclic amines in combination - assessment with a liver initiation model. Hirata A, Tsukamoto T, Sakai H, Takasu S, Ban H, Imai T, Totsuka Y, Nishigaki R, Wakabayashi K, Yanai T, Masegi T, Tatematsu M. Food Chem Toxicol; 2008 Jun 26; 46(6):2003-9. PubMed ID: 18331778 [Abstract] [Full Text] [Related]
29. Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol. Wanibuchi H, Wei M, Karim MR, Morimura K, Doi K, Kinoshita A, Fukushima S. Toxicol Pathol; 2006 Jun 26; 34(3):232-6. PubMed ID: 16698719 [Abstract] [Full Text] [Related]
30. 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis is not enhanced by CYP1A inducers, alpha- and beta-naphthoflavone: relationship to intralobular distribution of CYP1A expression. Suzuki S, Takeshita K, Doi Y, Asamoto M, Takahashi S, Naiki-Ito A, Shirai T. Toxicol Pathol; 2010 Jun 26; 38(4):583-91. PubMed ID: 20448087 [Abstract] [Full Text] [Related]
31. Comparison of initiation potential of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in an in vivo carcinogen bioassay system. Tsuda H, Takahashi S, Yamaguchi S, Ozaki K, Ito N. Carcinogenesis; 1990 Apr 26; 11(4):549-52. PubMed ID: 2322995 [Abstract] [Full Text] [Related]
38. Modifying effects of propolis on MeIQx promotion of rat hepatocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation. Kawabe M, Lin C, Kimoto N, Sano M, Hirose M, Shirai T. Nutr Cancer; 2000 Apr 26; 37(2):179-86. PubMed ID: 11142091 [Abstract] [Full Text] [Related]
39. Detailed low-dose study of 1,1-bis(p-chlorophenyl)-2,2,2- trichloroethane carcinogenesis suggests the possibility of a hormetic effect. Sukata T, Uwagawa S, Ozaki K, Ogawa M, Nishikawa T, Iwai S, Kinoshita A, Wanibuchi H, Imaoka S, Funae Y, Okuno Y, Fukushima S. Int J Cancer; 2002 May 01; 99(1):112-8. PubMed ID: 11948501 [Abstract] [Full Text] [Related]
40. Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Frantz CE, Bangerter C, Fultz E, Mayer KM, Vogel JS, Turteltaub KW. Carcinogenesis; 1995 Feb 01; 16(2):367-73. PubMed ID: 7859370 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]